NCT02980757View on ClinicalTrials.gov

Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2014

Conditions
Comparative Bioavailability
Interventions
DRUG

Gliclazide 120 mg MR Tablets Formula A

DRUG

Gliclazide 120 mg MR Tablets

DRUG

Gliclazide 120 mg MR Tablets Formula B

Trial Locations (1)

Unknown

International Pharmaceutical Research Center, Amman

Sponsors
All Listed Sponsors
lead

Disphar International B.V.

INDUSTRY